Cerulean Pharma appoints new board member
This article was originally published in Scrip
Cerulean Pharma has named Stuart A Arbuckle to its board of directors, effective 26 June. Mr Arbuckle is currently executive vice president and chief commercial officer at Vertex Pharmaceuticals where he oversees Vertex's global commercial team. Prior to joining Vertex, Mr Arbuckle held multiple commercial leadership roles at Amgen, including vice-president and general manager, oncology business unit.